Responding to my previous post, this SEC document, notwithstanding having to painstakingly sift through legalese, does suggest that the options and warrants will transfer "solely" to the parent company.
"Accordingly, from and after the Neurotrope Effective Time: (i) each Neurotrope Warrant assumed by Parent may be exercised solely for shares of Parent Common Stock;"
"In addition, each outstanding option to purchase Neurotrope common stock or outstanding warrant to purchase common stock that has not previously been exercised prior to the closing of the Mergers (the “Closing”) will be converted into equivalent options and warrants to purchase shares of Petros common stock and will be adjusted to give effect to the exchange ratios set forth in the Merger Agreement."
Market Data 
Markets 
AI
